Decompensated cirrhosis is defined as an acute deterioration in liver function in a patient with cirrhosis and is characterized by jaundice, ascites, hepatic encephalopathy, hepatorenal syndrome, or ...
Smartphone-based assessment of jaundice in patients with decompensated cirrhosis is feasible and accurate, mirroring levels of bilirubin and its correlations with clinical parameters, according to a ...
Ramat Gan, Israel, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs ...
Previous prospective and retrospective studies had suggested that statins may improve decompensated cirrhosis. In this trial, giving patients simvastatin and rifaximin alongside standard of care did ...
Chief, Digestive Disease Institute, North Shore University Hospital-Long Island Jewish Medical Center, Manhasset, New York; Associate Professor of Medicine, New York University School of Medicine, New ...
Investigators led by Elisa Pose, MD, PhD, a research fellow in the Liver Unit at the Hospital Clínic de Barcelona in Barcelona, Spain, randomly assigned 237 patients with advanced, mostly ...
Developing improved care models for decompensated liver disease is one of the major clinical challenges in gastroenterology and hepatology, and in a recent landmark study, published in Hepatology, ...
Please provide your email address to receive an email when new articles are posted on . Patients who received simvastatin plus rifaximin experienced similar rates of complications as those treated ...
Please provide your email address to receive an email when new articles are posted on . Use of nonselective beta-blockers was associated with stage 2 acute kidney injury in decompensated cirrhosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results